COMMUNIQUÉS West-GlobeNewswire

Spine Injury Solutions Schedules Third Quarter Fiscal Year 2018 Conference Call for November 13, 2018 at 11:00 a.m. EST
07/11/2018
HOUSTON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Spine Injury Solutions, Inc. (OTCQB:SPIN), will hold an investor conference call on Tuesday, November 13, at 11:00 am (EST) to discuss its financial results for Q3 Fiscal Year [...]
Xenon Pharmaceuticals to Present at the Stifel 2018 Healthcare Conference
07/11/2018
BURNABY, British Columbia, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that Dr. Simon Pimstone, Xenon's Chief Executive Officer [...]
Ziopharm Oncology to Present at the Stifel 2018 Healthcare Conference on Nov. 14
07/11/2018
BOSTON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq: ZIOP), today announced that Laurence Cooper, M.D., Ph.D., Chief Executive Officer, will present at the Stifel 2018 Healthcare Conference in New [...]
TRACON Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
07/11/2018
SAN DIEGO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]
miRagen Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
07/11/2018
Continued advancements of three clinical stage microRNA-targeted product candidates currently being evaluated for multiple potential indications in four clinical trials Global Phase 2 SOLAR clinical trial of cobomarsen [...]
TearLab Corporation Reports Third Quarter 2018 Financial Results
07/11/2018
ESCONDIDO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today reported its consolidated financial results for the third quarter ended September 30, 2018. All [...]
Arbutus Reports 2018 Third Quarter Financial Results and Provides Corporate Update
07/11/2018
- AB-506, a second-generation capsid inhibitor, advanced to HBV patient portion of Phase 1a/1b clinical trial - ONPATTRO™ (patisiran) approved by the U.S. Food and Drug Administration (FDA) and the European Medicines [...]
Platelet-Rich Plasma (PRP) Treatments for Hair Loss Now Available at Skin and Laser Surgery Center
07/11/2018
MCLEAN, Va., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Dr. Bajoghli and the Skin and Laser Surgery Center of McLean, Virginia now offer the Platelet-Rich Plasma treatment for patients with thinning hair and/ or hair loss. Hair [...]
Curetis raises €8.9 million through private placements
07/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO [...]
DBV Technologies: Monthly information regarding the total number of voting rights and total number of shares of the Company
07/11/2018
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
DBV Technologies : Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social
07/11/2018
Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social (Article 223-16 du Règlement Général de l'Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]
Neovacs announces in vivo Proof of Concept success for its IL-4 / IL-13 Kinoid a new Therapeutic Vaccine to treat Mite-induced Asthma
07/11/2018
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE Neovacs announces in vivo Proof of Concept success for its IL-4 / IL-13 Kinoid a new Therapeutic Vaccine to treat Mite-induced Asthma IL-4 / IL-13 Kinoid induces strong [...]
Néovacs : preuve de concept in vivo de son nouveau vaccin thérapeutique dans le traitement de l'asthme
07/11/2018
COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE Néovacs annonce avoir établi la preuve de concept in vivo de son nouveau vaccin thérapeutique IL-4/IL-13 Kinoi de dans le traitement de l'asthme induit [...]
Virtusa Partners with the IBRI to Drive Innovation and Accelerate Therapy Research
07/11/2018
SOUTHBOROUGH, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Virtusa Corporation (NASDAQ GS:VRTU), a global provider of digital strategy, digital engineering, and IT outsourcing services that accelerates business outcomes for [...]
New Eyes Opens Fifth Convenient Las Vegas Location in the Southwest
07/11/2018
New Eyes announces a new location in the southwest region of the Las Vegas Valley, offering a wide range of surgical and medical eye care services such as premier laser cataract surgery, corneal procedures, glaucoma [...]
Konica Minolta Announces New Tools in Exa® Enterprise Imaging Platform to Increase Clinical Productivity and Enhance Communication
07/11/2018
WAYNE, N.J., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc. will showcase new features and tools for the Exa Enterprise Imaging platform at RSNA 2018. Exa is a breakthrough solution comprised [...]
SeeThruEquity Initiates .03 Target on HempAmericana (HMPQ)
07/11/2018
NEW YORK, Nov. 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has [...]
Momenta Pharmaceuticals Announces Publication of Phase 1 Study Data for Anti-FcRn Antibody, M281
07/11/2018
Full data shows safety, tolerability and proof-of-mechanism in healthy volunteers CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) today announced the publication of [...]
Biomerica’s Diagnostic Product Guides Exclusionary Diet Treatment to Successfully Alleviate Symptoms of Ulcerative Colitis (UC) in Prospective Clinical Stud
07/11/2018
Eliminating positive foods identified by Biomerica’s diagnostic product showed statistically significant improvements (p<0.05) in both Quality of Life (FDA Instrument) and disease activity (Mayo Score) in UC patients [...]

Pages